Oxymorphone Hydrochloride
NDC 13107-103, Oxymorphone Hydrochloride, tablet, from Aurolife Pharma, LLC.
- Product NDC
- 13107-103
- Status
- Listed
- Labeler
- Aurolife Pharma, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204459
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/13107-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXYMORPHONE HYDROCHLORIDE5 mg/1
Pharmacologic classes
Full Opioid Agonists [MoA]; Opioid Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 13107-103-01 | 13107010301 | 100 TABLET in 1 BOTTLE (13107-103-01) |
| 13107-103-30 | 13107010330 | 30 TABLET in 1 BOTTLE (13107-103-30) |
| 13107-103-99 | 13107010399 | 1000 TABLET in 1 BOTTLE (13107-103-99) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/22c7652a-aa16-4fa8-89d9-517e69059068
Use it
Look up 13107-103 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/13107-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 13107-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.